Skip to content

The effect of cognitive- behavioural therapy on drug use control and treatment among addicted female

A randomized clinical trial comparing the efficacy of cognitive behavioral therapy on drug use control and treatment among women drug users on Maintaining Methadone Therapy (MMT)

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2015060621684N2
Enrollment
40
Registered
2015-08-30
Start date
2015-06-22
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Addiction. Mental and behavioural disorders due to psychoactive substance use

Interventions

Intervention 1: Experimental Group: Brief cognitive and behavioural therapy. This guide, reported by Baker et al 2003, details a brief cognitive behavioural intervention specifically designed for regu
Behavior
Experimental Group: Brief cognitive and behavioural therapy. This guide, reported by Baker et al 2003, details a brief cognitive behavioural intervention specifically designed for regular amphetamine
Control Group: No intervention

Sponsors

Vice Chancellor for Research, Shiraz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 55 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Being addicted female; being on methadone maintaining therapy for at least 3 months; having a history of relapse during MMT program for at least 3 times over the past one month; completing inform consent; having not a history of severe drug toxicity. Exclusion criteria: Having severe physical and neurological illness;Having severe mental and personality disorders.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Retention in Methadone Maintenance Treatment without relapse. Timepoint: Before intervention, immediately after intervention, 3 months after intervention. Method of measurement: Opium treatment index; severity of dependence scale; timeline follow back; rapid urine test.

Secondary

MeasureTime frame
The trend of reducing in drug use. Timepoint: Before intervention, immediately after intervention, 3 months after intervention. Method of measurement: Questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMahmood AminiLari

Shiraz HIV/ AIDS Research Center, Shiraz University of Medical Sciences

maminil@yahoo.com+98 71 3738 6272

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026